共查询到10条相似文献,搜索用时 62 毫秒
1.
研究了扩散加权的NMR在区分冠心病患者和正常人的血清中的可能应用,证明了扩散加权的NMR与主成分分析(PCA)相结合是将冠心病血清从正常血清中识别出来的有效方法。分子自扩散运动加权的NMR能够有效抑制小分子代谢物的共振信号强度,从而使血脂和血蛋白的NMR特征更为明显。最佳的扩散权重因子(b)约为0.85×107s/cm2,增加或降低扩散权重因子都会影响识别效率。研究结果表明,分子量极小的代谢物(乳酸等)及相对较大的脂蛋白(VLDL)对区分两类血清的贡献较小。在最佳的b值条件下,高密度脂蛋白(HDL)和低密度脂蛋白(LDL)对区分两类血清的贡献得以提高,从而获得更好的区分效果。 相似文献
2.
3.
稀土对大鼠尿液成分影响的核磁共振研究 总被引:4,自引:0,他引:4
目前,稀土生物效应的研究已进入了分子和细胞水平,但在活体动物内研究稀土的作用情况还不多见。稀土化合物随食物进入动物体内后,会对动物体内的器官、组织、细胞产生一定影响,将导致其体液容量、分布、电解质浓度等方面的变化。现代NMR技术是目前药理毒理学研究的有效手段之一,它具有简便、全面、快捷、非破坏性等优点,可用于对体液样品的检测和研究。本文采用现代核磁共振技术研究了稀土化合物硝酸镧灌胃给药后对Wistar大鼠尿液中代谢产物的影响,为阐明稀土化合物的毒理学机制和稀土的进一步开发利用提供理论依据。 相似文献
4.
Chun YANG Wen Yi HE Li Jun LI Rui Ming XU Shou Ren ZHANG Zeper ABLIZ Yi Kang SI* Institute of Materia Medica Chinese Academy of Medical Sciences Peking Union Medical College Beijing 《中国化学快报》2001,(6)
Brodimoprim,a trimethoprim analogue diaminopyrimidine, 2,4-diamino-5-(4'-bromo-3',5'-dimethoxybenzyl) pyrimidine, is a new inhibitor of bacterial dihydro folate reductases (OHFRs), it shows activity against a broad spectrum of Gram-positive and negative-bacteria. Recently we reported the results of the study on the metabolites of brodimoprim in vivo with SPE-NMR method (solid phase extraction coupled with nuclear magnetic resonance), five metabolites were detected in rat urine1. They were … 相似文献
5.
高场核磁共振波谱在多糖结构研究中的应用 总被引:21,自引:0,他引:21
随着高场核磁共振波谱(NMR)技术飞速发展,它在多糖的结构研究中发挥着日益重要的作用,不仅对共 结构,而且对于多糖在溶液中或固体状态下的构象以及动力学特性,NMR分析也是最有力的工具。本文综述了高场NMR技术在分析多糖结构方面的应用。 相似文献
6.
7.
8.
Abubakar Shaaban Hadzliana Zainal Nor Azlina Khalil Fatimatuzzahra Abd Aziz Ewe Seng Chng Chin-Hoe Teh Mustapha Mohammed Baharudin Ibrahim 《Molecules (Basel, Switzerland)》2022,27(7)
Background: Low-dose aspirin (LDA) is the backbone for secondary prevention of coronary artery disease, although limited by gastric toxicity. This study aimed to identify novel metabolites that could predict LDA-induced gastric toxicity using pharmacometabolomics. Methods: Pre-dosed urine samples were collected from male Sprague-Dawley rats. The rats were treated with either LDA (10 mg/kg) or 1% methylcellulose (10 mL/kg) per oral for 28 days. The rats’ stomachs were examined for gastric toxicity using a stereomicroscope. The urine samples were analyzed using a proton nuclear magnetic resonance spectroscopy. Metabolites were systematically identified by exploring established databases and multivariate analyses to determine the spectral pattern of metabolites related to LDA-induced gastric toxicity. Results: Treatment with LDA resulted in gastric toxicity in 20/32 rats (62.5%). The orthogonal projections to latent structures discriminant analysis (OPLS-DA) model displayed a goodness-of-fit (R2Y) value of 0.947, suggesting near-perfect reproducibility and a goodness-of-prediction (Q2Y) of −0.185 with perfect sensitivity, specificity and accuracy (100%). Furthermore, the area under the receiver operating characteristic (AUROC) displayed was 1. The final OPLS-DA model had an R2Y value of 0.726 and Q2Y of 0.142 with sensitivity (100%), specificity (95.0%) and accuracy (96.9%). Citrate, hippurate, methylamine, trimethylamine N-oxide and alpha-keto-glutarate were identified as the possible metabolites implicated in the LDA-induced gastric toxicity. Conclusion: The study identified metabolic signatures that correlated with the development of a low-dose Aspirin-induced gastric toxicity in rats. This pharmacometabolomic approach could further be validated to predict LDA-induced gastric toxicity in patients with coronary artery disease. 相似文献
9.